Pacific Biosciences of California Inc
PACB
|
|
| |
|
| Trading Volume | 239,416 |
|
|
11.72 - 1.35 |
| Market Cap Full | $ 363.7M |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | 9.1% | -61.9% | 41.6% |
| Q2 | - | - | -62.9% | 14.9% |
| Q3 | - | - | -34.4% | -37.2% |
| Q4 | - | - | -12.7% | 21.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 9.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -33.6 | -15.1 | -32.4 | -58.6 | 18.7 | -26.6 | 53 | -34.4 | - | - | - | -5.2 |
| 2023 | |||||||||||
| 35.6 | -18.1 | 27.5 | -8.5 | 16.8 | 7.4 | -0.7 | -14.6 | -26 | -26 | 37.2 | 15.7 |
| 2022 | |||||||||||
| -46.7 | 1.9 | -17.1 | -32.8 | -11.2 | -21.5 | -1.1 | 34.1 | -0.9 | 45.3 | 27.4 | -23.9 |
| 2021 | |||||||||||
| 24.7 | -5.5 | 9 | -10.4 | -9.4 | 29.3 | -8.1 | -2.6 | -18.4 | 4 | -12.7 | -9.6 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.4 | -0.4 | -0.5 |
| Q2 | -0.3 | -0.3 | -0.2 |
| Q3 | -0.3 | -0.3 | 0.1 |
| Q4 | 0 | -0.4 | -0.3 |
| A | -0.9 | -1.4 | -0.9 |